NVSEF News and Press, Novartis Ag Basel Akt From 04/23/23

2023-04-23 12:00:00 ET Biotech deal-making is on a roll, with more than $12B worth of transactions announced over the past week alone, and, according to industry observers, the trend is expected to continue in 2023, supported by macro and certain industry-specific factors. Days after Me...

2023-04-21 13:45:05 ET Summary Shares of CRISPR-Cas9 genomic editor Intellia Therapeutics, Inc. have retreated over 80% since hitting an all-time intraday high of $202.73 in late June 2021. Despite the pullback, very early returns suggest a functional cure for HAE and (possibly) A...

2023-04-19 06:39:26 ET Summary Biotechnology is the second worst performer in healthcare, significantly lagging behind the US market year-to-date. However, there could now be opportunities to get a bargain in the biotechs. Kura Oncology may be of interest to investors as this US b...

2023-04-14 11:28:52 ET Summary Pharmaceuticals/biotechnology is the only subsector with good value and quality scores. Healthcare equipment is the most overvalued one. IXJ: A global alternative to XLV. 10 stocks cheaper than their peers in April. This monthly art...

2023-04-11 10:41:37 ET TG Therapeutics ( NASDAQ: TGTX ) shares rallied for the second straight session on Tuesday to reach a new 52-week high after B. Riley Securities cited a rising trend in demand for the company’s newly approved multiple sclerosis therapy Briumvi. In D...

2023-03-30 09:03:39 ET Cancer-focused biotech Erasca ( NASDAQ: ERAS ) extended gains in the pre-market Thursday after Mizhuho Securities initiated its coverage with a Buy rating and a $9 per share target, citing its upcoming data readouts and liquidity position. “We l...

2023-03-29 15:05:26 ET Summary This portfolio uses historical performance and qualitative business traits to determine low-risk assets. These assets are leading their class and represent sectors that offer lower volatility. Backtesting proves that the constituents outperform t...

2023-03-27 05:45:26 ET The shares of Dutch biotech Pharming Group N.V. ( NASDAQ: PHAR ) added ~24% on Monday in the Amsterdam stock exchange on the announcement of U.S. approval for the rare immune disorder therapy Joenja co-developed with Novartis ( NVS ). The FDA...

2023-03-24 17:46:35 ET Summary Dimensional International Value ETF is an actively managed fund investing in value stocks outside the U.S. Almost 30% of DFIV assets are in financials. Otherwise, it is well-diversified across countries and holdings. DFIV is slightly better t...

2023-03-23 14:00:00 ET Summary In today’s article, I will present 10 dividend growth companies that I currently consider to be particularly attractive. The 10 selected picks have shown an Average Dividend Growth Rate of 12.92% over the past 5 years. At the same time, th...